Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes.
Desheng LiangDavid S CramHu TanSiyuan LinpengYingdi LiuHuaiyu SunYu ZhangFeng TianHongmin ZhuMengnan XuHua WangFuli YuLingqian WuPublished in: Genetics in medicine : official journal of the American College of Medical Genetics (2019)
NIPS-Plus yielded high PPVs for common aneuploidies and DiGeorge syndrome, and moderate PPVs for other MMS. Our results present compelling evidence that NIPS-Plus can be used as a first-tier pregnancy screening method to improve detection rates of clinically significant fetal chromosome abnormalities.